Event Details
2021 Translational Medicine Symposium Return to listing


The 2021 Translational Medicine Symposium is co-sponsored by the Program in Translational Medicine and the Cancer Cell Biology Training Program.  The symposium will be virtual this year and will take place via Zoom and Gathertown formats. 

Symposium Agenda

  • 10:30-11:15am Dr. Ellen Puré Keynote Address (Zoom). Title: Local and long-distance networks determine cancer cell fate.
  • 11:15-11:45am Trainee talks (Zoom)
  • 11:45-12:15 lunch break
  • 12:15-1:00 Dr. Ricardo Dolmetsch Keynote Address (Zoom). Title: Curative gene therapies for severe diseases of the nervous system.
  • 1:00-1:30 Trainee talks (Zoom)
  • 2:00-2:45 Career Discussions with 2 keynote speakers and 3 Trans Med external advisory board members (GatherTown)
  • 3:00-4:00 Poster/Illustrated Abstract session (GatherTown)

All zoom sessions will use this link:

Dial by your location
        +1 929 205 6099 US (New York)
        +1 301 715 8592 US (Washington DC)
        888 475 4499 US Toll-free
Meeting ID: 939 8261 8465
Passcode: 873214
Find your local number: https://zoom.us/u/abvZZu1zi7
GatherTown links will be shared at a later date with registrants.
About the Keynote Speakers:
Ellen Puré, PhD
Dr. Ellen Puré is the chair of the Department of Biomedical Sciences and the director of the Penn Vet Cancer Center at the University of Pennsylvania. Dr. Puré has discovered several novel ways through which our immune system regulates inflammation, and her work continues to focus on characterizing how various cells and molecules contribute to inflammation and fibrosis, especially in the context of chronic inflammatory diseases and cancer.
Ricardo Dolmetsch, PhD
Dr. Ricardo Dolmetsch is responsible for uniQure's gene therapy research activities, as well as nonclinical development, process development, analytical development and vector development. Dr. Dolmetsch joins uniQure from Novartis Institutes for Biomedical Research where he served as the Global Head of Neuroscience since 2013. He has led the development of treatments for neurodegenerative and neuropsychiatric diseases, including rare genetically defined disorders. Prior to NIBR, Dr. Dolmetsch was a Professor at Stanford Medical School. He obtained his Ph.D. in neuroscience from Stanford University and conducted his postdoctoral training at Harvard University Medical School and Children's Hospital Boston.
  Location: Koury Oral Health Sciences Building
  Date: Tuesday, April 06, 2021
  Time: 10:30 AM - 4:00 PM
  Sponsor: Training Initiative for Biological and Biomedical Sciences (TIBBS) - Cancer Cell Biology Training Program
  Price: Free
  For more information, contact the event administrator: Patrick Brandt pdbrandt@email.unc.edu

UNC - Chapel Hill